AUSTIN, Texas, May 19, 2016 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that management will be presenting at the UBS Global Healthcare Conference to be held from May 23-25, 2016 in New York, NY. LDR Holding’s presentation will take place on Wednesday, May 25, 2016 at 8:30 am Eastern Time.
About LDR Holding Corporation
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR’s primary products are the Mobi-C® cervical disc replacement device and MIVo™ portfolio of products which include a range of devices to support lumbar and cervical fusion procedures. The Mobi-C and MIVo platforms are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease. For more information regarding LDR Holding, visit www.ldr.com.
CONTACT: Robert McNamara Executive Vice President and Chief Financial Officer LDR Holding Corporation 512-344-3333 Matthew Norman Director, Investor Relations LDR Holding Corporation 512-344-3408
Source:LDR Holding Corporation